Bobigny

The trials here

What the 4 trials at this site are about, from their registry records.

Conditions

• Chronic myeloid leukaemia1 trial
• Coronary artery disease1 trial
• Familial hypercholesterolaemia1 trial
• High blood pressure1 trial
• Melanoma1 trial
• Stroke1 trial

Phase

• Phase 32 trials
• Phase 21 trial

Status

• Active, not recruiting2 trials
• Completed1 trial
• Terminated1 trial

Lead sponsor

• Novartis Pharmaceuticals4 trials

Running trials

• Active, not recruiting

  Asciminib Prospective Non Interventional Study as 3rd Line Therapy or More to Treat Adult Patients With CML- CP in Real World Setting in France

  NCT06092879· Novartis Pharmaceuticals· Source

• Active, not recruiting

  A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.

  NCT05739383· Phase 3· Novartis Pharmaceuticals· Source

Closed trials

• Completed

  An Efficacy, Safety, Tolerability and Dose Finding Study of XXB750 in Resistant Hypertension Patients.

  NCT05562934· Phase 2· Novartis Pharmaceuticals· Source

• Terminated

  A Study of the Anti-PD1 Antibody PDR001, in Combination With Dabrafenib and Trametinib in Advanced Melanoma

  NCT02967692· Phase 3· Novartis Pharmaceuticals· Source